Follow

Nanoform Finland Oyj

Nasdaq First North GM Helsinki (Finland)
Nasdaq First North GM Stockholm (Sweden)

Nanoform is an nanoparticle medicine enabling company. The Company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nanoforming services.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
NANOFH
FI4000330972
Nasdaq First North GM Helsinki
Finland (FI)
Details of share in Nanoform Finland Oyj with ticker NANOFH
Status
Active
Amount of instruments
66 600 443
Currency
EUR
First trading date
04 Jun 2020
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
NANOFS
FI4000330972
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Nanoform Finland Oyj with ticker NANOFS
Status
Active
Amount of instruments
66 600 443
Currency
SEK
Segment
First North Premier
First trading date
04 Jun 2020
Directed issue
Sign in to buy
People
Edward Hæggström
CEO
Miguel Calado
Chairman of the board
Mads Laustsen
Board member
Albert Hæggström
Board member
Jeanne Thoma
Board member
Company Details
Sector
HEALTH CARE

Address
Viikinkaari 4
Zip code
FI-00790
City/district
Helsinki
Country
Finland (FI)
Registration number
2730572-8
LEI code
743700JJO2NU8LBS1592
First trade date
04 Jun 2020
Registration date
07 Dec 2015
Short name
Nanoform

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More